Practical Checklist Before Enrolling in Amble Before starting an intake with Amble or any GLP-1 telehealth platform, a woman should have the following information available: Current weight and height (BMI calculation) List of all medications, including oral contraceptives, metformin, or any insulin Recent labs within the past 12 months, including TSH, HbA1c, and a metabolic panel if available Documentation of any prior weight-loss pharmacotherapy, including which agent, dose, and reason for stopping Clarity on monthly budget including both platform fee and pharmacy cost Understanding that she will need to self-administer a subcutaneous injection weekly and store the pen correctly (refrigerated at 2-8 degrees Celsius) A woman who checks all these boxes, meets BMI criteria, has no contraindications, and can sustain the financial commitment for 12-24 months is a genuinely appropriate candidate for a GLP-1 program through a platform like Amble

Key takeaways Ro weight loss reviews highlight high member satisfaction, with users praising the convenience, provider communication, and ongoing support that help them stay on track throughout their weight loss journey
Changes in glucose tolerance: Studies have shown that tesamorelin can mildly impair insulin sensitivity, which could matter for bodybuilders managing carb intake
Dulaglutide (Trulicity) Dulaglutide is a GLP-1 receptor agonist that is given once a week
2014;306:E137887
Vaira, L